Switch theme
Sign up to access all valuation multiples
Shiseido is a leading Japanese cosmetics manufacturer. Founded in 1872, the first Western-style pharmacy in Ginza, Tokyo, it is one of the oldest cosmetics companies globally. Shiseido’s suite of 31 brands, including its namesake brand and luxury Clé de Peau Beauté, has an 9.3% share of Japan’s beauty and personal care market and 18.3% share of Japan’s premium segment according to Euromonitor. It is also ranked No. 3 after Estée Lauder and L’Oréal, with 7.6% market share in the global premium skincare space, thanks to a strong presence in China. China, Japan, and western markets each account for about 25% of sales, followed by 15% of travel retail, and 6% in Asia. Its distribution channels include department stores, drugstores, specialty retailers, travel retailers, and e-commerce.
1927
46.7K+
LTM Revenue $6.8B
LTM EBITDA $705M
$8.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Shiseido has a last 12-month revenue (LTM) of $6.8B and a last 12-month EBITDA of $705M.
In the most recent fiscal year, Shiseido achieved revenue of $6.8B and an EBITDA of $555M.
Shiseido expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Shiseido valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $6.8B | XXX | $6.8B | XXX | XXX | XXX |
| Gross Profit | $5.2B | XXX | $5.2B | XXX | XXX | XXX |
| Gross Margin | 77% | XXX | 76% | XXX | XXX | XXX |
| EBITDA | $705M | XXX | $555M | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 8% | XXX | XXX | XXX |
| EBIT | $243M | XXX | $52.0M | XXX | XXX | XXX |
| EBIT Margin | 4% | XXX | 1% | XXX | XXX | XXX |
| Net Profit | -$15.4M | XXX | -$74.2M | XXX | XXX | XXX |
| Net Margin | 0% | XXX | -1% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $962M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Shiseido's stock price is JPY 2330 (or $16).
Shiseido has current market cap of JPY 931B (or $6.4B), and EV of JPY 1.18T (or $8.1B).
See Shiseido trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8.1B | $6.4B | XXX | XXX | XXX | XXX | $-0.04 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Shiseido has market cap of $6.4B and EV of $8.1B.
Shiseido's trades at 1.2x EV/Revenue multiple, and 14.7x EV/EBITDA.
Equity research analysts estimate Shiseido's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Shiseido has a P/E ratio of -414.9x.
See valuation multiples for Shiseido and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $6.4B | XXX | $6.4B | XXX | XXX | XXX |
| EV (current) | $8.1B | XXX | $8.1B | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | 1.2x | XXX | XXX | XXX |
| EV/EBITDA | 11.5x | XXX | 14.7x | XXX | XXX | XXX |
| EV/EBIT | 33.5x | XXX | 156.3x | XXX | XXX | XXX |
| EV/Gross Profit | 1.6x | XXX | n/a | XXX | XXX | XXX |
| P/E | -414.9x | XXX | -86.1x | XXX | XXX | XXX |
| EV/FCF | 67.9x | XXX | -513.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialShiseido's last 12 month revenue growth is 1%
Shiseido's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Shiseido's rule of 40 is 12% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Shiseido's rule of X is 12% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Shiseido and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 1% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Margin | 10% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | 11% | XXX | -5% | XXX | XXX | XXX |
| Rule of 40 | 12% | XXX | 9% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 12% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 75% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Shiseido acquired XXX companies to date.
Last acquisition by Shiseido was XXXXXXXX, XXXXX XXXXX XXXXXX . Shiseido acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Shiseido founded? | Shiseido was founded in 1927. |
| Where is Shiseido headquartered? | Shiseido is headquartered in Japan. |
| How many employees does Shiseido have? | As of today, Shiseido has 46.7K+ employees. |
| Who is the CEO of Shiseido? | Shiseido's CEO is Mr. Kentaro Fujiwara. |
| Is Shiseido publicy listed? | Yes, Shiseido is a public company listed on TKS. |
| What is the stock symbol of Shiseido? | Shiseido trades under 4911 ticker. |
| When did Shiseido go public? | Shiseido went public in 1949. |
| Who are competitors of Shiseido? | Similar companies to Shiseido include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Shiseido? | Shiseido's current market cap is $6.4B |
| What is the current revenue of Shiseido? | Shiseido's last 12 months revenue is $6.8B. |
| What is the current revenue growth of Shiseido? | Shiseido revenue growth (NTM/LTM) is 1%. |
| What is the current EV/Revenue multiple of Shiseido? | Current revenue multiple of Shiseido is 1.2x. |
| Is Shiseido profitable? | Yes, Shiseido is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Shiseido? | Shiseido's last 12 months EBITDA is $705M. |
| What is Shiseido's EBITDA margin? | Shiseido's last 12 months EBITDA margin is 10%. |
| What is the current EV/EBITDA multiple of Shiseido? | Current EBITDA multiple of Shiseido is 11.5x. |
| What is the current FCF of Shiseido? | Shiseido's last 12 months FCF is $120M. |
| What is Shiseido's FCF margin? | Shiseido's last 12 months FCF margin is 2%. |
| What is the current EV/FCF multiple of Shiseido? | Current FCF multiple of Shiseido is 67.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
